Stay updated on Safety and Tolerability of Nivolumab and Cabiralizumab Clinical Trial

Sign up to get notified when there's something new on the Safety and Tolerability of Nivolumab and Cabiralizumab Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Safety and Tolerability of Nivolumab and Cabiralizumab Clinical Trial page

  1. Check
    7 days ago
    No Change Detected
  2. Check
    14 days ago
    Change Detected
    Summary
    Only minor UI/version changes are observed: a new 'Revision: v3.4.2' label and removal of the older funding/operating status notice. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.5%
    Check dated 2026-02-11T04:42:39.000Z thumbnail image
  3. Check
    21 days ago
    Change Detected
    Summary
    Added a government funding lapse notice with status updates and links to cc.nih.gov and opm.gov; added release note Revision: v3.4.1; removed the prior release note Revision: v3.4.0. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.5%
    Check dated 2026-02-04T04:22:23.000Z thumbnail image
  4. Check
    28 days ago
    Change Detected
    Summary
    Added 'Show glossary' and updated footer/status labels to 'Last Update Submitted that Met QC Criteria' and 'No FEAR Act Data', alongside a revision note 'Revision: v3.4.0'. Removed 'Last Update Submitted that met QC Criteria', 'No FEAR Act data', and prior 'Revision: v3.3.4'.
    Difference
    0.2%
    Check dated 2026-01-28T01:52:32.000Z thumbnail image
  5. Check
    42 days ago
    Change Detected
    Summary
    Revision: v3.3.4 added and v3.3.3 removed; changes are limited to revision metadata and do not affect study details or user actions. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.1%
    Check dated 2026-01-14T00:46:08.000Z thumbnail image
  6. Check
    64 days ago
    Change Detected
    Summary
    Footer shows Revision: v3.3.3 and removal of the HHS Vulnerability Disclosure and Revision: v3.3.2 notices. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.1%
    Check dated 2025-12-23T07:40:35.000Z thumbnail image
  7. Check
    85 days ago
    Change Detected
    Summary
    The page shows a revision update from v3.3.1 to v3.3.2. No study content, eligibility criteria, outcomes, or other critical information was changed. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.1%
    Check dated 2025-12-01T16:27:56.000Z thumbnail image

Stay in the know with updates to Safety and Tolerability of Nivolumab and Cabiralizumab Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Safety and Tolerability of Nivolumab and Cabiralizumab Clinical Trial page.